Atlas-based GABA-mapping with 3D MEGA-MRSI: Cross-correlation to single voxel MRS
dc.contributor.author | Ma, Ruoyun E. | |
dc.contributor.author | Murdoch, James B. | |
dc.contributor.author | Bogner, Wolfgang | |
dc.contributor.author | Andronesi, Ovidiu | |
dc.contributor.author | Dydak, Ulrike | |
dc.contributor.department | Radiology and Imaging Sciences, School of Medicine | en_US |
dc.date.accessioned | 2023-06-26T11:01:39Z | |
dc.date.available | 2023-06-26T11:01:39Z | |
dc.date.issued | 2021 | |
dc.description.abstract | The purpose of this work is to develop and validate a new atlas-based metabolite quantification pipeline for edited magnetic resonance spectroscopic imaging (MEGA-MRSI) that enables group comparisons of brain structure-specific GABA levels. By using brain structure masks segmented from high-resolution MPRAGE images and coregistering these to MEGA-LASER 3D MRSI data, an automated regional quantification of neurochemical levels is demonstrated for the example of the thalamus. Thalamic gamma-aminobutyric acid + coedited macromolecules (GABA+) levels from 21 healthy subjects scanned at 3 T were cross-validated both against a single-voxel MEGA-PRESS acquisition in the same subjects and same scan sessions, as well as alternative MRSI processing techniques (ROI approach, four-voxel approach) using Pearson correlation analysis. In addition, reproducibility was compared across the MRSI processing techniques in test-retest data from 14 subjects. The atlas-based approach showed a significant correlation with SV MEGA-PRESS (correlation coefficient r [GABA+] = 0.63, P < 0.0001). However, the actual values for GABA+, NAA, tCr, GABA+/tCr and tNAA/tCr obtained from the atlas-based approach showed an offset to SV MEGA-PRESS levels, likely due to the fact that on average the thalamus mask used for the atlas-based approach only occupied 30% of the SVS volume, ie, somewhat different anatomies were sampled. Furthermore, the new atlas-based approach showed highly reproducible GABA+/tCr values with a low median coefficient of variance of 6.3%. In conclusion, the atlas-based metabolite quantification approach enables a more brain structure-specific comparison of GABA+ and other neurochemical levels across populations, even when using an MRSI technique with only cm-level resolution. This approach was successfully cross-validated against the typically used SVS technique as well as other different MRSI analysis methods, indicating the robustness of this quantification approach. | en_US |
dc.eprint.version | Author's manuscript | en_US |
dc.identifier.citation | Ma RE, Murdoch JB, Bogner W, Andronesi O, Dydak U. Atlas-based GABA mapping with 3D MEGA-MRSI: Cross-correlation to single-voxel MRS. NMR Biomed. 2021;34(5):e4275. doi:10.1002/nbm.4275 | en_US |
dc.identifier.uri | https://hdl.handle.net/1805/33946 | |
dc.language.iso | en_US | en_US |
dc.publisher | Wiley | en_US |
dc.relation.isversionof | 10.1002/nbm.4275 | en_US |
dc.relation.journal | NMR in Biomedicine | en_US |
dc.rights | Publisher Policy | en_US |
dc.source | PMC | en_US |
dc.subject | Magnetic resonance spectroscopic imaging | en_US |
dc.subject | Creatinine | en_US |
dc.subject | Dipeptides | en_US |
dc.subject | Glutamic acid | en_US |
dc.subject | Glutamine | en_US |
dc.title | Atlas-based GABA-mapping with 3D MEGA-MRSI: Cross-correlation to single voxel MRS | en_US |
dc.type | Article | en_US |